SARTORIUS STEDIM BIOTECH (SDMHF) Financials
SDMHF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 7.8 billion | 5.1 billion |
| 2023-09-30 | 8.0 billion | 5.3 billion |
| 2023-06-30 | 5.2 billion | 2.6 billion |
| 2023-03-31 | 5.1 billion | 2.6 billion |
SDMHF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 130.0 million | ? |
| 2023-09-30 | -10.5 million | ? |
| 2023-06-30 | 300000 | ? |
| 2023-03-31 | 49.8 million | ? |
SDMHF Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 39.8 million |
| 2023-09-30 | 35.5 million |
| 2023-06-30 | 158.9 million |
| 2023-03-31 | 148.6 million |
SDMHF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 116.6 million | - | 114.5 million |
| 2023-09-30 | 118.7 million | - | 120.1 million |
| 2023-06-30 | 124.3 million | - | 110.0 million |
| 2023-03-31 | 113.0 million | - | 111.6 million |
SDMHF Shares Outstanding
SDMHF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 102.8 million | 37.0 million | 55.1 million | 115.5 million |
| 2023-09-30 | 108.9 million | 28.4 million | 39.5 million | 110.2 million |
| 2023-06-30 | 146.1 million | 28.8 million | 35.0 million | 108.2 million |
| 2023-03-31 | 115.8 million | 35.4 million | 37.5 million | 115.3 million |
SDMHF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 706.8 million | 453.6 million |
| 2023-09-30 | 666.9 million | 386.0 million |
| 2023-06-30 | 675.7 million | 350.8 million |
| 2023-03-31 | 726.1 million | 351.6 million |
SDMHF
Price: $229.31
Forward Dividend Yield: 0.32%
Payout Ratio: 20.68%
Dividend Per Share: 0.74 USD
Earnings Per Share: 3.61 USD
P/E Ratio: 47.58
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 21.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 15
DGR3: 4.28%
DGR5: 5.92%
DGR10: 11.86%